References
- Miyasaka Y, Takizawa H. Lung diseases accompanying collagen disease. Diagn Treat 1997;85:67–72.
- Nagai S. Lung diseases. Jpn J Clin Med 1999;57(2):143–9.
- Hamasaki K, Inokuma S. Lung diseases associated with collagen disease. Clin Ftheumatol 1999;11:257–64.
- Abe S, Takahashi H. Kinetics of lung surfactant protein and indicators of its activity in patients with idiopathic interstitial pneu-monia. Intern Med 1996;77(4):664–6.
- Kuroki Y, Takahashi H. Pulmonary surfactant proteins SP-A and SP-D. Jpn J Chin Med 1999;57:309–12.
- Abe S, Takahashi H. Diffuse infiltrative lung disease — new clinical biomarker in diffuse interstitial pneumonia. Intern Med 2001; 40(2):159–62.
- Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637–42.
- Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989;96:68–73.
- Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000;162:1109–14.
- Sagawa A, Shinohara M, Tanimura K, Kitano A, Mikami M, Uno M, et al. Diagnosis and treatment of lung diseases associated with scleroderma — using markers of interstitial pneumonia (SP-D and KL-6). Ftheumatology 2000;23(429–35.
- Sagawa A. Interstitial pneumonitis and serum markers (SP-D and KL-6) in collagen vascular disease. Jpn J Chin Immunol 2004; 27(2):55–63.
- Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000;162:258–63.